Viewing Study NCT03141203


Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2026-05-14 @ 9:28 PM
Study NCT ID: NCT03141203
Status: COMPLETED
Last Update Posted: 2022-05-18
First Post: 2017-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients
Sponsor:
Organization: